Article
An update on type 2B von Willebrand disease.
Expert review of hematology - 1 Apr 2014
Mikhail Sameh, Aldin Ehab Saad, Streiff Michael, Zeidan Amer
Abstract excerpt
Type 2B von Willebrand disease (VWD) accounts for fewer than 5% of all VWD patients. In this disease, mutations in the A1 domain result in increased von Willebrand factor (VWF) binding to platelet GPIbα receptors, causing increased platelet clearance and preferential loss of high molecular weight VWF multimers. Diagnosis is complicated because of significant clinical variations even among patients with identical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
